Biological treatments, namely, biological preparations for use in the clinical, medicinal, and therapeutic treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases; biopharmaceutical reagents for medical use, for use in gene therapy for the treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases; biopharmaceutical preparations for human use for the treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases
Pharmaceuticals